MassBio Lunch and Learn IVAL Contract Research Service: In vitro screening for human-specific adverse drug properties Speaker: Albert P. Li, PhD, President and CEO of IVAL Clinical trial failure is a major challenge for drug development. Reasons for the failures are unexpected adverse drug properties that, due to species difference, ... Read More »
Please visit IVAL at the 57th Annual Meeting of the Society of Toxicology, March 11–15, 2018 in San Antonio, Texas.
Please visit IVAL at the 57th Annual Meeting of the Society of Toxicology, March 11–15, 2018 in San Antonio, Texas. Poster Session: Late-Breaking 2: Toxicokinetics Date and Time: Thursday, March 15, 2018; 8:30 AM to 11:30 AM Location: Convention Center Hall 1 Poster Board number: P147 Poster Title: A Novel ... Read More »
Hepatocyte and Enterocyte Research Organization (HERO) Workshop and Symposium Date: December 4th and 5th, 2017 Workshop (Includes HERO Symposium): December 4th and 5th, 2017 Symposium Only: December 5th 2017 Full Program of Workshop and Symposium Li HERO Workshop Hepatocyte and Enterocyte Technologies for Drug Development Hepatocyte and Enterocyte Laboratory Introduction ... Read More »
IVAL’s MetMax™ Technology Wins EPA’s Transform Tox Challenge IVAL’s MetMax™ system has been selected as one of the five winners in the Transform Toxicity Challenge by National Toxicology Program (NTP) and the United States Environmental Protection Agency (EPA). High-throughput screening (HTS) assays are deployed to rapidly test whether some of ... Read More »
IVAL Webinar: MetMax™ Hepatocytes and Enterocytes (Patent Pending) View the recorded webinar video here Check out the electronic version of IVAL’s posters at the 21st North American ISSX Meeting; September 24 - 28, 2017, Rhode Island Convention Center Providence, Rhode, USA. MetMax™ Pooled Donor Human Hepatocytes: A Novel In Vitro ... Read More »
KMT Hepatech and In Vitro ADMET Laboratories to Offer Human Hepatocytes from Chimeric Mouse View the Press Release Here. Visit IVAL in our own hometown Baltimore, Maryland at SOT (March 12 - 16, 2017), and learn more about two new IVAL products to add to your drug metabolism tool box: ... Read More »
IVAL is named as a semi-finalist in the “Transform Tox Testing Challenge” created to improve chemical screening.
IVAL is named as a semi-finalist in the "Transform Tox Testing Challenge" created to improve chemical screening. IVAL continues its series of innovative approaches to the comprehensive understanding of toxicity. The Transform Tox Testing Challenge was created by a coalition of Federal Agencies: the Environmental Protection Agency (EPA) and the ... Read More »
2016 IVAL Annual Workshop and Conference: Novel In Vitro ADMET Technologies for Drug Development April 11th – 12th 2016 IVAL Annual Workshop: Hands-on workshop for in vitro test systems: Hepatocytes, enterocytes, and hepatocyte spheroids April 12th 2016 IVAL Annual Conference: Novel In Vitro ADMET Technologies for Drug Development IVAL Boston ... Read More »
SOT’s 55th Annual Tox Expo Date: March 14 – 16, 2016 Location: New Orleans, LA Booth: #804 Posters Human Enterocytes: Isolation, Cryopreservation, Characterization, And Application In The Evaluation Of Drug-food Interactions - Abstract Number 3146 / Poster Board number P406 - 3/16/2016 1:15 to 4:30 PM, CC Exhibit Hall Prolonged ... Read More »
IVAL Webinar: Hep-I-Spheres: 3D in vitro liver test systems for ADME-Tox research February 24, 2016 View the Webinar. Hep-I-Spheres, IVAL's newly-developed hepatocyte spheroids, are a useful tool for preclinical toxicity assessment of new compounds. These uniform and organized cell aggregates offer liver-like morphology and function in long-term cultures that can closely ... Read More »